Molecular Characterization of HPV16 E6 and E7 Variants among Women with Cervical Cancer in Morocco

References (42)

1. 1 Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [DOI]
2. 2 The causal relation between human papillomavirus and cervical cancer [DOI]
3. 3 Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update [DOI]
4. 4 Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective [DOI]
5. 5 The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations [DOI]
6. 6 Asian-American Variants of Human Papillomavirus 16 and Risk for Cervical Cancer: a Case-Control Study [DOI]
7. 7 Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments [DOI]
8. 8 Diversifying Selection in Human Papillomavirus Type 16 Lineages Based on Complete Genome Analyses [DOI]
9. 9 Human Papillomavirus Type 16 Genetic Variants: Phylogeny and Classification Based on E6 and LCR [DOI]
10. 10 Risk for High-Grade Cervical Intraepithelial Neoplasia Associated with Variants of Human Papillomavirus Types 16 and 18 [DOI]
11. 11 Increased Risk for Cervical Disease Progression of French Women Infected with the Human Papillomavirus Type 16 E6-350G Variant [DOI]
12. 12 Risks for Persistence and Progression by Human Papillomavirus Type 16 Variant Lineages Among a Population-Based Sample of Danish Women [DOI]
13. 13 Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. [DOI]
14. 14 Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms [DOI]
15. 15 Human Papillomavirus Type 16 E6 Amino Acid 83 Variants Enhance E6-Mediated MAPK Signaling and Differentially Regulate Tumorigenesis by Notch Signaling and Oncogenic Ras [DOI]
16. 16 Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer [DOI]
17. 17 Human papillomavirus variants and squamous neoplasia of the cervix [DOI]
18. 18 Analysis of human papillomavirus type‐16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer [DOI]
19. 19 Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis [DOI]
20. 20 Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease [DOI]
21. 21 Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population [DOI]
22. 22 Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment [DOI]
23. 23 E6 molecular variants of human papillomavirus (HPV) type 16: An updated and unified criterion for clustering and nomenclature [DOI]
24. 24 Analysis of mutations in the E6/E7 oncogenes and L1 gene of human papillomavirus 16 cervical cancer isolates from China [DOI]
25. 25 Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression [DOI]
26. 26 The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer [DOI]
27. 27 Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind [DOI]
28. 28 Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes [DOI]
29. 29 Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization [DOI]
30. 30 Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women [DOI]
31. 31 Major Sequence Variants in E7 Gene of Human Papillomavirus Type 16 from Cervical Cancerous and Noncancerous Lesions of Korean Women [DOI]
32. 32 Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China [DOI]
33. 33 Molecular variants of human papillomavirus type 16 and 18 and risk for cervical Neoplasia in Portugal [DOI]
34. 34 Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasias [DOI]
35. 35 HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP [DOI]
36. 36 p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women [DOI]
37. 37 Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16 [DOI]
38. 38 The Uganda study on HPV variants and genital cancers [DOI]
39. 39 Identification of a naturally processed HLA A0201‐restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein [DOI]
40. 40 Molecular variants of human papillomavirus type 16 and risk for cervical neoplasia in South Africa [DOI]
41. 41 Prevalence of Human Papilloma Virus Infection in Malignant Lesions of the Uterine Cervix in Morocco
42. 42 J. Virol. Methods [DOI]

Cited by 6

Showing 3 of 6 known citations — external sources report more than can currently be individually listed.

Related research

• A Statistical Approach towards Cervical Cancer Awareness among Women in Ghana — shares topic coverage
• Experiences of Women Living with Cervical Cancer: A Study in the Tamale Metropolis — shares topic coverage
• Retrospective Analysis of Cancer Cervix at Awal Bros Batam Hospital in 2020-2022 — shares topic coverage
• Sequence Variations of Human Papillomavirus Type 16 E6 and E7 Genes in Cervical Cancer Isolates from Gabon — shares topic coverage
• Cervical Cancer Knowledge and Prevention Practices among Female Civil Servants in Awka South Local Government Area, Anambra State — shares topic coverage